About Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time treatment for previously treated advanced melanoma, now approved in three global markets and available at more than 95 authorized treatment centers. The Iovance TIL platform spans registrational trials and next-generation programs in additional solid tumors, including gene-edited and IL-12 tethered TIL therapies, next-generation IL-2, and precision immuno-oncology approaches. As the first and only company to take TIL therapy from concept to a broadly accessible commercial treatment, Iovance operates as an end-to-end cell therapy company, anchored by fully owned, centralized U.S.-based manufacturing that is scaled to serve thousands of cancer patients worldwide each year. For more information, please visit www.iovance.com.
Amtagvi® and its accompanying design marks, Proleukin®, Iovance®, and IovanceCares™ are trademarks and registered trademarks of Iovance Biotherapeutics, Inc. or its subsidiaries. All other trademarks and registered trademarks are the property of their respective owners.
Information on Iovance’s broad, industry-leading patent portfolio is available on the Intellectual Property page on www.iovance.com.
Overview
The Associate Director, Publications, is a core member of the medical affairs team and will report to the Director of Publications. This role will support the development and execution of publication plans, for lifileucel and pipeline products. The Associate Director, Publications works closely with various functional areas within the organization to communicate accurate, consistent, and timely information regarding products and therapeutic areas. The Associate Director will work closely with the cross-functional data generation team (Clinical development, HEOR, Biometrics, preclinical and research) and engage with healthcare professional experts and authors. The role will ensure compliance with publication-related policies and procedures.
Essential Functions and Responsibilities
- Subject matter expert and internal liaison for lifileucel and pipeline products with ability to work independently and lead/ influence cross-functionally.
- Support and facilitate comprehensive cross-functional global publication planning, including generation and execution of annual publication plans and presence at scientific congresses, with an understanding of how these activities support the overall business strategy, and including identification and prioritization of regional and local publication needs
- Execute publication plans including partnering with agency partners to ensure delivery of accurate and appropriate publications on time, within budget, and adhering to policy
- Partner with Scientific Communications and Field Medical leads to support the incorporation of published data into medical materials (e.g., field medical, medical affairs training)
- Ensure the publication development process and all materials produced are in compliance with Iovance policy and guidelines including ICMJE, PhRMA, and GPP
- Leverage best practices and implement efficient processes to optimize publication efforts across medical affairs
- Support the execution and implementation of iEnvision for publications management
- Must adhere to Iovance Biotherapeutics’ core values, policies, procedures, and business ethics.
- Perform miscellaneous duties as assigned.
Required Education, Skills, and Knowledge
- Advanced scientific/clinical degree required (e.g., PharmD, Ph.D., MD) in a science-related field with 10+ years relevant industry experience in medical/scientific publications either in the pharmaceutical industry or related (e.g., medical communication agency) industry preferred
- Experience in Cell Therapy or IO required
- Experience in the development and medical writing of peer-reviewed publications and congress materials (abstracts, posters, presentations)
- Experience with Publication management systems such as Datavision is required
- Strong oncology writing experience
- Strong HEOR experience required
- Experience with publications planning and execution, including literature gap analysis
- Excellent communication, organizational, and time management skills
- Experience in literature searches, literature evaluation, and drug information and educational concepts
Physical Demands and Activities Required
The physical demands described here represent those an employee may encounter while performing the essential functions of this job. Reasonable accommodation may be provided to enable individuals to perform these functions.
- Ability to remain in a stationary position for extended periods
- Ability to move about within an office or remote workspace and exert up to 10 pounds of force occasionally
- Visual acuity sufficient for preparing and analyzing data, viewing computer screens, and extensive reading
- Repetitive motion involving wrists, hands, and/or fingers
- Ability to communicate effectively to exchange information
- Ability to engage in analytical, conceptual, and problem‑solving activities in a dynamic business environment
Mental: Clear and conceptual thinking ability; excellent judgment, troubleshooting, problem-solving, analysis, and discretion; ability to manage work-related stress; ability to manage multiple priorities simultaneously with a sense of urgency; and ability to meet deadlines
Work Environment
This job operates in a professional or remote office environment and requires operating standard office equipment and keyboards.
#li-remote
The annual base salary we reasonably expect to pay is listed. Individual pay decisions depend on various factors, such as primary work location, complexity and responsibility of the role, job duties/requirements, and relevant education, experience and skills.
The statements contained in this document are intended to describe the general nature and level of work being performed by a colleague assigned to this description. They are not intended to constitute a comprehensive list of functions, duties, or local variances. Management retains the discretion to add or to change the duties of the position at any time.
Iovance is committed to cultivating and offering a diverse and inclusive work environment. As an equal-opportunity employer, our employees and applicants will be considered without regard to an individual’s race, color, religion, sex, pregnancy, national origin, age, physical and mental disability, marital status, sexual orientation, gender identity, gender expression, genetic information, military and veteran status, and any other characteristic protected by applicable law. If you need assistance or accommodation to apply to one of our opportunities, please contact [email protected].
By voluntarily providing information and clicking “Submit Application”, you explicitly consent to the collection and use of your personal information for the purposes described above and in our Candidate Privacy Notice.
Skills Required
- Advanced scientific or clinical degree such as PharmD, PhD, or MD in a science-related field
- 10+ years of relevant industry experience in medical or scientific publications, preferably in pharmaceutical or medical communications agency settings
- Master's degree in a science-related field with 12+ years of relevant industry experience
- Experience in cell therapy or immuno-oncology
- Experience developing and writing peer-reviewed publications and congress materials, including abstracts, posters, and presentations
- Experience with publication management systems such as Datavision
- Strong health economics and outcomes research experience
- Experience with publication planning and execution, including literature gap analysis
- Excellent communication, organizational, and time-management skills
- Experience developing scientific communication platforms or scientific statements
- Experience conducting literature searches and evaluations, and developing drug information and educational concepts
Iovance Biotherapeutics, Inc. Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Iovance Biotherapeutics, Inc. and has not been reviewed or approved by Iovance Biotherapeutics, Inc..
-
Fair & Transparent Compensation — Pay is considered fair to competitive across many roles, with base salaries, bonuses, and equity often positioned at or above market levels. Compensation is frequently characterized as a relative bright spot versus other aspects of the workplace.
-
Healthcare Strength — Medical coverage is described as flexible with low or no employee cost, bolstered by company HSA contributions, dental/vision, EAP, and wellness programs. Company‑paid life and disability insurance further reinforce the health and protection package.
-
Equity Value & Accessibility — Equity participation is supported through an Employee Stock Purchase Plan alongside competitive stock components in total rewards. Company materials and filings indicate accessible equity programs available broadly across employee groups.
Iovance Biotherapeutics, Inc. Insights
What We Do
Iovance Biotherapeutics (NASDAQ: IOVA) aims to improve patient care for people living with cancer. Iovance is investigating T cell-based therapies, known as tumor infiltrating lymphocytes (TIL), which use a patient’s own immune cells to attack cancer. Our unique Iovance TIL technology platform has generated novel cell therapies that are currently in clinical studies for multiple cancers. We are adding to our talented team as we actively prepare for our initial commercial launch, advance our research and development efforts, and build our internal manufacturing capabilities. Iovance is headquartered in the San Francisco Bay Area. Our Iovance Cell Therapy Center (iCTC), a state-of-the-art manufacturing facility, is located in Philadelphia. We also have a research site in Tampa, Florida. Any information expressed by Iovance is subject to the risk factors and information on forward-looking statements contained in its filings with the Securities and Exchange Commission and available here: https://ir.iovance.com/sec-filings
